{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:15:35Z","timestamp":1792512935753,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","award":["201807\\u201310"],"award-info":[{"award-number":["201807\\u201310"]}],"id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.cbi.2025.111606","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T19:19:31Z","timestamp":1749755971000},"page":"111606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Insights into the diagnostic and prognostic value of paraoxonase 1-related variables and inflammatory markers in community-acquired pneumonia"],"prefix":"10.1016","volume":"418","author":[{"given":"Frederic","family":"Ballester","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Gabald\u00f3-Barrios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Jim\u00e9nez-Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Pujol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Iftimie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3165-3640","authenticated-orcid":false,"given":"Jordi","family":"Camps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Joven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cbi.2025.111606_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41572-021-00259-0","article-title":"Pneumonia","volume":"7","author":"Torres","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"3","key":"10.1016\/j.cbi.2025.111606_bib2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000479089","article-title":"Risk factors for community-acquired pneumonia in adults: a systematic review of observational studies","volume":"94","author":"Almirall","year":"2017","journal-title":"Respiration"},{"issue":"1","key":"10.1016\/j.cbi.2025.111606_bib3","first-page":"6","article-title":"Defining community-acquired pneumonia as a public health threat: arguments in favor from Spanish investigators","volume":"8","author":"Cill\u00f3niz","year":"2020","journal-title":"Med. Sci."},{"key":"10.1016\/j.cbi.2025.111606_bib4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.rmed.2016.10.015","article-title":"Burden and risk factors of ambulatory or hospitalized CAP: a population based cohort study","volume":"121","author":"Kolditz","year":"2016","journal-title":"Respir. Med."},{"issue":"11","key":"10.1016\/j.cbi.2025.111606_bib6","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1136\/thx.2009.129627","article-title":"Comparison of clinical characteristics and performance of pneumonia severity score and CURB-65 among younger adults, elderly and very old subjects","volume":"65","author":"Chen","year":"2010","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.cbi.2025.111606_bib7","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.cbi.2025.111606_bib8","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/cam4.240","article-title":"Predicting pneumonia mortality using CURB-65, PSI, and patient characteristics in patients presenting to the emergency department of a comprehensive cancer center","volume":"3","author":"Gonzalez","year":"2014","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.cbi.2025.111606_bib9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12931-022-02117-3","article-title":"Unmet needs in pneumonia research: a comprehensive approach by the CAPNETZ study group","volume":"23","author":"Pletz","year":"2022","journal-title":"Respir. Res."},{"issue":"3","key":"10.1016\/j.cbi.2025.111606_bib10","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1152\/physrev.00032.2017","article-title":"Integrative physiology of pneumonia","volume":"98","author":"Quinton","year":"2018","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.cbi.2025.111606_bib11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s41479-023-00106-8","article-title":"Innate immune responses in pneumonia","volume":"15","author":"Korkmaz","year":"2023","journal-title":"Pneumonia"},{"issue":"11","key":"10.1016\/j.cbi.2025.111606_bib12","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.6061\/clinics\/2012(11)17","article-title":"Biomarkers in community-acquired pneumonia: a state-of-the-art review","volume":"67","author":"Seligman","year":"2012","journal-title":"Clinics"},{"issue":"8","key":"10.1016\/j.cbi.2025.111606_bib13","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.3390\/ijms20082004","article-title":"Biomarkers in pneumonia-beyond procalcitonin","volume":"20","author":"Karakioulaki","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.cbi.2025.111606_bib14","doi-asserted-by":"crossref","first-page":"609","DOI":"10.21037\/atm.2020.02.182","article-title":"Diagnostic markers for community-acquired pneumonia","volume":"8","author":"Ito","year":"2020","journal-title":"Ann. Transl. Med."},{"issue":"1","key":"10.1016\/j.cbi.2025.111606_bib15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13613-024-01323-0","article-title":"Biomarkers in pulmonary infections: a clinical approach","volume":"14","author":"P\u00f3voa","year":"2024","journal-title":"Ann. Intensive Care"},{"issue":"Pt B","key":"10.1016\/j.cbi.2025.111606_bib16","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.cbi.2016.04.005","article-title":"J, Paraoxonases, mitochondrial dysfunction and non-communicable diseases","volume":"259","author":"Camps","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2025.111606_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110553","article-title":"Paraoxonase-1: how a xenobiotic detoxifying enzyme has become an actor in the pathophysiology of infectious diseases and cancer","volume":"380","author":"Camps","year":"2023","journal-title":"Chem. Biol. Interact."},{"issue":"7","key":"10.1016\/j.cbi.2025.111606_bib18","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3390\/biom11070971","article-title":"On the role of paraoxonase-1 and chemokine ligand 2 (C-C motif) in metabolic alterations linked to inflammation and disease. A 2021 Update","volume":"11","author":"Camps","year":"2021","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.cbi.2025.111606_bib19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/10408360802610878","article-title":"The paraoxonases: role in human diseases and methodological difficulties in measurement","volume":"46","author":"Camps","year":"2009","journal-title":"Crit. Rev. Clin. Lab Sci."},{"key":"10.1016\/j.cbi.2025.111606_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.atherosclerosis.2006.07.024","article-title":"Serum paraoxonase-1 activity and concentration are influenced by human immunodeficiency virus infection","volume":"194","author":"Parra","year":"2007","journal-title":"Atherosclerosis"},{"issue":"9","key":"10.1016\/j.cbi.2025.111606_bib21","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s10096-016-2679-8","article-title":"Preliminary study on serum paraoxonase-1 status and chemokine (C-C motif) ligand 2 in hospitalized elderly patients with catheter-associated asymptomatic bacteriuria","volume":"35","author":"Iftimie","year":"2016","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"6","key":"10.1016\/j.cbi.2025.111606_bib22","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.clinbiochem.2015.11.006","article-title":"A preliminary study of paraoxonase-1 in infected patients with an indwelling central venous catheter","volume":"49","author":"Iftimie","year":"2016","journal-title":"Clin. Biochem."},{"issue":"13\u201314","key":"10.1016\/j.cbi.2025.111606_bib23","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.clinbiochem.2017.04.016","article-title":"Paraoxonases and infectious diseases","volume":"50","author":"Camps","year":"2017","journal-title":"Clin. Biochem."},{"issue":"6","key":"10.1016\/j.cbi.2025.111606_bib24","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3390\/antiox10060991","article-title":"Clinical performance of paraoxonase-1-related variables and novel markers of inflammation in coronavirus disease-19. A machine learning approach","volume":"10","author":"Rodr\u00edguez-Tom\u00e0s","year":"2021","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.cbi.2025.111606_bib25","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1186\/s40064-016-3145-x","article-title":"HDL-c levels predict the presence of pleural effusion and the clinical outcome of community-acquired pneumonia","volume":"5","author":"Saballs","year":"2016","journal-title":"SpringerPlus"},{"issue":"6","key":"10.1016\/j.cbi.2025.111606_bib26","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.2165\/00003495-200060060-00004","article-title":"Diagnosis of pneumonia and monitoring of infection eradication","volume":"60","author":"Ruiz","year":"2000","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.cbi.2025.111606_bib27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify low-risk patients with community-acquired pneumonia","volume":"336","author":"Fine","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2025.111606_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.106884","article-title":"Comparison of the prognostic performance of the CURB-65 and a modified version of the pneumonia severity index designed to identify high-risk patients using the International Community-Acquired Pneumonia Collaboration Cohort","volume":"200","author":"Barlas","year":"2022","journal-title":"Respir. Med."},{"issue":"12","key":"10.1016\/j.cbi.2025.111606_bib29","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.7326\/0003-4819-117-12-1003","article-title":"Emotional support and survival after myocardial infarction. A prospective, population-based study of the elderly","volume":"117","author":"Berkman","year":"1992","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.cbi.2025.111606_bib30","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3109\/14756366.2014.959511","article-title":"Human serum paraoxonase-1 (hPON1): in vitro inhibition effects of moxifloxacin hydrochloride, levofloxacin hemihidrate, cefepime hydrochloride, cefotaxime sodium and ceftizoxime sodium","volume":"30","author":"T\u00fcrke\u015f","year":"2015","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.cbi.2025.111606_bib31","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1134\/S0006297906010068","article-title":"Amphenicol and macrolide derived antibiotics inhibit paraoxonase enzyme activity in human serum and human hepatoma cells (HepG2) in vitro","volume":"71","author":"Sinan","year":"2006","journal-title":"Biochemistry (Mosc)."},{"issue":"4","key":"10.1016\/j.cbi.2025.111606_bib32","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1053\/j.jvca.2023.12.035","article-title":"Methylprednisolone does not enhance paraoxonase 1 activity during cardiopulmonary bypass surgery-A randomized, controlled clinical trial","volume":"38","author":"Taleska \u0160tupica","year":"2024","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"issue":"3","key":"10.1016\/j.cbi.2025.111606_bib33","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1080\/07391102.2021.2014971","article-title":"In silico investigation of the interactions of certain drugs proposed for the treatment of Covid-19 with the paraoxonase-1","volume":"41","author":"Duzgun","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"4","key":"10.1016\/j.cbi.2025.111606_bib34","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2174\/1574884711666160915153433","article-title":"Pharmacological interactions of paraoxonase 1 (PON1): a HDL-bound antiatherogenic enzyme","volume":"11","author":"Mahrooz","year":"2016","journal-title":"Curr. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.cbi.2025.111606_bib35","first-page":"372","article-title":"Role of antioxidant property of carvedilol in mild to moderate hypertensive patients: a prospective open-label study","volume":"38","author":"Ayashi","year":"2016","journal-title":"Indian J. Pharmacol."},{"issue":"2","key":"10.1016\/j.cbi.2025.111606_bib36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1590\/s0102-865020180020000004","article-title":"Investigation of the antioxidant effects of pheniramine maleate and nebivolol on testicular damage in rats with experimentally induced testis torsion","volume":"33","author":"Yuvanc","year":"2018","journal-title":"Acta Cir. Bras."},{"key":"10.1016\/j.cbi.2025.111606_bib37","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.freeradbiomed.2016.07.011","article-title":"Biochemical indices of oxidative stress and inflammation in the evaluation of peripheral artery disease","volume":"97","author":"Fort-Gallifa","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2025.111606_bib38","author":"Cacho-Calvo"},{"issue":"1","key":"10.1016\/j.cbi.2025.111606_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2008.11.001","article-title":"Paraoxonase 1 (PON1) status and substrate hydrolysis","volume":"235","author":"Richter","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.cbi.2025.111606_bib40","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/clinchem\/48.2.261","article-title":"Serum paraoxonase activity: a new additional test for the improved evaluation of chronic liver damage","volume":"48","author":"Ferr\u00e9","year":"2002","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.cbi.2025.111606_bib41","first-page":"60","article-title":"Paraoxonase 1 phenotype and paraoxonase activity in asthmatic patients, Iran","volume":"14","author":"Sarioglu","year":"2015","journal-title":"J. Allergy Asthma Immunol."},{"issue":"2","key":"10.1016\/j.cbi.2025.111606_bib42","first-page":"161","article-title":"Paraoxonase activity and phenotype distribution in patients with chronic obstructive pulmonary disease, Eurasian J","volume":"52","author":"Sarioglu","year":"2020","journal-title":"M\u00e9d. Sur"},{"issue":"2","key":"10.1016\/j.cbi.2025.111606_bib43","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.freeradbiomed.2008.03.023","article-title":"Immunochemical analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissues","volume":"45","author":"Marsillach","year":"2008","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.cbi.2025.111606_bib44","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1161\/01.ATV.21.4.542","article-title":"Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids","volume":"21","author":"Reddy","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.cbi.2025.111606_bib45","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/clinchem\/39.4.561","article-title":"Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine","volume":"39","author":"Zweig","year":"1993","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cbi.2025.111606_bib48","series-title":"Sample Size Tables for Clinical Studies","author":"Machin","year":"2009"},{"issue":"2","key":"10.1016\/j.cbi.2025.111606_bib49","article-title":"Lipidomic and metabolomic changes in community-acquired and COVID-19 pneumonia","volume":"65","author":"Saballs","year":"2024","journal-title":"J. Lipid Res."},{"issue":"10","key":"10.1016\/j.cbi.2025.111606_bib50","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1080\/17476348.2024.2409264","article-title":"The unique metabolic and lipid profiles of patients with severe COVID-19 compared to severe community-acquired pneumonia: a potential prognostic and therapeutic target","volume":"18","author":"Ib\u00e1\u00f1ez-Prada","year":"2024","journal-title":"Expet Rev. Respir. Med."},{"issue":"4","key":"10.1016\/j.cbi.2025.111606_bib51","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1086\/650312","article-title":"Paraoxonase-1 gene haplotypes are associated with metabolic disturbances, atherosclerosis, and immunologic outcome in HIV-infected patients","volume":"201","author":"Parra","year":"2010","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.cbi.2025.111606_bib52","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3390\/biom12070879","article-title":"Usefulness of the measurement of serum paraoxonase-1 arylesterase activity in the diagnoses of COVID-19","volume":"12","author":"Gabald\u00f3","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.cbi.2025.111606_bib53","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/978-3-319-09665-0_15","article-title":"HDL in infectious diseases and sepsis","volume":"224","author":"Pirillo","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"issue":"2","key":"10.1016\/j.cbi.2025.111606_bib54","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11883-020-00901-4","article-title":"High-density lipoproteins and serum amyloid A (SAA)","volume":"23","author":"Webb Nr","year":"2021","journal-title":"Curr. Atheroscler. Rep."},{"issue":"2","key":"10.1016\/j.cbi.2025.111606_bib55","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/cvr\/cvx237","article-title":"Regulation of low-density lipoprotein cholesterol by intestinal inflammation and the acute phase response","volume":"114","author":"Herbert","year":"2018","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.cbi.2025.111606_bib56","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/biof.1205","article-title":"The dual nature of HDL: anti-Inflammatory and pro-Inflammatory","volume":"41","author":"Namiri-Kalantari","year":"2015","journal-title":"Biofactors"},{"issue":"2","key":"10.1016\/j.cbi.2025.111606_bib57","first-page":"97","article-title":"The pleiotropic role of HDL in autoimmune diseases","volume":"27","author":"Parra","year":"2015","journal-title":"Cl\u00edn. Invest. Arterioscler."},{"issue":"2","key":"10.1016\/j.cbi.2025.111606_bib58","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.atherosclerosis.2005.07.028","article-title":"High C-reactive protein and low paraoxonase1 in diabetes as risk factors for coronary heart disease","volume":"186","author":"Mackness","year":"2006","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.cbi.2025.111606_bib59","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.bbrc.2004.04.056","article-title":"Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cells","volume":"318","author":"Mackness","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.cbi.2025.111606_bib60","first-page":"237","article-title":"Paraoxonase, oxidized low density lipoprotein, monocyte chemoattractant protein-1 and adhesion molecules are associated with macrovascular complications in patients with type 2 diabetes mellitus","volume":"105","author":"Sozer","year":"2014","journal-title":"Minerva Med."},{"issue":"6","key":"10.1016\/j.cbi.2025.111606_bib61","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2174\/156652411796268713","article-title":"The role of combined assessment of defense against oxidative stress and inflammation in the evaluation of peripheral arterial disease","volume":"11","author":"Rull","year":"2011","journal-title":"Curr. Mol. Med."},{"issue":"19","key":"10.1016\/j.cbi.2025.111606_bib62","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/eurheartj\/ehac094","article-title":"Targeting the CCL2-CCR2 axis for atheroprotection","volume":"43","author":"Georgakis","year":"2022","journal-title":"Eur. Heart J."},{"issue":"8","key":"10.1016\/j.cbi.2025.111606_bib63","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3390\/biom14080980","article-title":"Endothelial cell dysfunction due to molecules secreted by macrophages in sepsis","volume":"14","author":"He","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.cbi.2025.111606_bib64","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ajem.2024.11.093","article-title":"Procalcitonin advisory committee of the taiwan society of emergency medicine, GRADE-based procalcitonin guideline for emergency departments","volume":"89","author":"Lee","year":"2024","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.cbi.2025.111606_bib65","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1314623","article-title":"Cardiovascular insufficiency, abdominal sepsis, and patients' age are associated with decreased paraoxonase-1 (PON1) activity in critically ill patients with multiple organ dysfunction syndrome (MODS)","volume":"2019","author":"Bednarz-Misa","year":"2019","journal-title":"Dis. Markers"},{"key":"10.1016\/j.cbi.2025.111606_bib66","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/427378","article-title":"Low paraoxonase 1 activity predicts mortality in surgical patients with sepsis","volume":"2014","author":"Bojic","year":"2014","journal-title":"Dis. Markers"},{"issue":"4","key":"10.1016\/j.cbi.2025.111606_bib67","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3390\/diseases11040132","article-title":"C-reactive protein: pathophysiology, diagnosis, false test results and a novel diagnostic algorithm for clinicians","volume":"11","author":"Mouliou","year":"2023","journal-title":"Diseases"},{"issue":"11","key":"10.1016\/j.cbi.2025.111606_bib68","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.3390\/diagnostics13111869","article-title":"Diagnostic and prognostic roles of procalcitonin and other tools in community-acquired pneumonia: a narrative review","volume":"13","author":"Ozbay","year":"2023","journal-title":"Diagnostics"},{"issue":"9","key":"10.1016\/j.cbi.2025.111606_bib69","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac434","article-title":"Accuracy of C-reactive protein and procalcitonin for diagnosing bacterial infections among subjects with persistent fever in the tropics","volume":"9","author":"Van Duffel","year":"2022","journal-title":"Open Forum Infect. Dis."},{"issue":"18","key":"10.1016\/j.cbi.2025.111606_bib70","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.clinbiochem.2013.08.020","article-title":"Impaired paraoxonase-1 status in obese children. Relationships with insulin resistance and metabolic syndrome","volume":"46","author":"Ferr\u00e9","year":"2013","journal-title":"Clin. Biochem."},{"issue":"1","key":"10.1016\/j.cbi.2025.111606_bib71","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jhep.2005.12.018","article-title":"Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseases","volume":"45","author":"Ferr\u00e9","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cbi.2025.111606_bib72","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1476-511X-9-46","article-title":"Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment","volume":"9","author":"Marsillach","year":"2010","journal-title":"Lipids Health Dis."},{"issue":"9\u201310","key":"10.1016\/j.cbi.2025.111606_bib73","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.clinbiochem.2007.01.020","article-title":"Serum paraoxonase-1 in chronic alcoholics: relationship with liver disease","volume":"40","author":"Marsillach","year":"2007","journal-title":"Clin. Biochem."}],"updated-by":[{"DOI":"10.1016\/j.cbi.2025.111808","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000}}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279725002364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279725002364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:14:56Z","timestamp":1778876096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279725002364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":70,"alternative-id":["S0009279725002364"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111606","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights into the diagnostic and prognostic value of paraoxonase 1-related variables and inflammatory markers in community-acquired pneumonia","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111606","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111606"}}